Grant opportunity preview
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Offered by National Institutes of Health
HealthcareNationalJanuary 7, 2028
Opportunity summary
The overarching purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and/or early evaluation of strong candidate biomarkers and biomarker signatures that can be used as tools to facilitate the clinical development of neurotherape…
Sign in to review full eligibility requirements, application details, matching insights, and verified source links.